Emergency Medicine Cardiac Research and Education Group





CRUSADE
CRUSADE Quality Improvement Initiative

Launched in 2001, CRUSADE is a national quality improvement initiative, designed to increase the practice of evidence-based medicine for patients diagnosed with non-ST segment elevation acute coronary syndromes (NSTE ACS) (i.e., unstable angina or NSTE myocardial infarction).

Through a continuous cycle of data collection, performance feedback and quality improvement interventions, over 500 participating sites in the US are consistently improving the standard of care for patients with NSTE ACS. Because of the dedication of the participating hospitals to this mission, over 200,000 cases have been submitted to the CRUSADE database. For more information visit the CRUSADE website.

In 2007, a milestone occurred. Duke Clinical Research Institute and its CRUSADE leadership joined forces with the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR™) to launch a new initiative to improve the safety and outcomes for patients with ACS through the development of NCDR-ACTION™. This initiative will combine the data collection and quality reporting features of two leading national ACS registries to create the largest and most comprehensive national cardiovascular patient database ever developed. For more information visit the NCDR-ACTION Registry™ visit the website or call 800-257-4737 for more information.




LEGAL INFORMATION
Intellectual Property Rights:
The contents of this Web site are copyrighted. EMCREG-International (collectively, the "Company"), hereby authorize you to copy documents published on this Web site for non-commercial personal use only, provided that any copy of these documents which you make shall retain all copyright and other proprietary notices and any disclaimer contained on the documents. Except as expressly provided above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text or documents contained in this Web site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text or documents, without the express written consent of the Company. No information or statement contained herein shall be construed as conferring by implication or otherwise any license or right under any patent, copyright, trademark or other intellectual property right of the Company, or its affiliates, or any third party. Except as expressly provided above, no information or statement contained herein shall be construed as conferring any license or right under any EMCREG patent, copyright or trademark.

Disclaimers
The Company has undertaken reasonable efforts to include accurate and up-to-date information on its Web site. However, THIS WEB SITE IS PROVIDED "AS IS" AND THE COMPANY MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. THE COMPANY DOES NOT WARRANT THAT THE FUNCTIONS CONTAINED IN THE WEB SITE WILL BE UNINTERRUPTED OR ERROR FREE OR THAT THE WEB SITE OR THE SERVER THAT MAKES IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO THE ABOVE EXCLUSION MAY NOT APPLY TO YOU. All users agree that all access and use of this Web site and its content is at their own risk. Neither the Company nor any other party involved in creating, producing or delivering this Web site shall be liable in any manner for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this Web site, or any errors or omissions in the content. This Web site may provide links or references to other Internet sites maintained by third parties over whom the Company has no control. Such links are provided merely as a convenience to users of this Web site. The Company takes no responsibility for the content of such sites and makes no representations as to the accuracy or completeness of any information contained in such sites, and shall have no liability for any damages or injuries of any kind arising from such content or information.

This Website, as well as the contents of this Website, including all information, text, graphics, images, hyperlinks and other material including user contributions (the "Materials"), are for general educational purposes only and are not intended to be used for the purposes of providing medical treatment or attention or making medical or health-related decisions. This Website is not a substitute or replacement for medical advice. If you are seeking medical advice, we encourage you to consult a physician or other medical professional.

The Company, its affiliates, agents, directors, editors, employees, licensors, officers and web sponsors (collectively, the "EMCREG Entities") do not endorse any statements or opinions made in the Materials. EMCREG makes no claim to expert knowledge in the fields of medicine, pharmacology, diagnostic imaging, physiology or any other health-related field and is not able to determine the truthfulness, accuracy, reliability, currency or completeness of the Materials.

EMCREG will attempt, where possible, to identify on the Website the authorship of the Materials. However, such information may not be possible to verify and there can be no assurance that such identification will be accurate in all cases.

The EMCREG Entities do not take any responsibility for the Materials and will not be responsible for any damages to users of the Website, however caused. The views expressed in the Materials are those of the authors and are not necessarily those of the EMCREG Entities. Information in the Materials may not be current and may be superseded by more recent information published by EMCREG or by other parties. USE OF THE WEBSITE OR ITS MATERIALS AND ANY RELIANCE ON THEM WILL BE AT YOUR OWN RISK.

No Warranties or Liability
The EMCREG Entities make no representations or warranties of any kind regarding this Website or the Materials, all of which are provided on an "AS IS" and "WHEN AVAILABLE" basis. The EMCREG Entities disclaim all representations and warranties, including any implied warranties and conditions of merchantable quality, non-infringement and fitness for a particular purpose, including, without limiting the foregoing, the suitability of the Materials as a basis for medical decisions. The EMCREG Entities make no representation or warranty as to the accuracy, reliability, veracity, completeness or suitability of the Materials or about the results to be obtained using the Materials.

IN NO EVENT WILL THE EMCREG ENTITIES BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DECISION MADE OR ACTION TAKEN (OR NOT TAKEN) BY YOUR IN RELIANCE ON THE MATERIALS POSTED TO THIS WEBSITE.

Links to Other Sites
This Website may contain links to other Websites which are provided solely as a convenience to you and not as an endorsement, recommendation or certification by the EMCREG Entities of the contents of such other Websites. The EMCREG Entities will not be responsible for the content of any such Websites (including, without limitation, those sites that provide links to this Website) and do not make any representations or warranties regarding any other Websites or the contents or materials on such Websites. If you decide to access other Websites, you do so solely at your own risk.

Indemnity
You agree to defend, indemnify and hold harmless the EMCREG Entities, as well as any third parties mentioned at this Website, from and against any and all claims, actions or demands, including without limitation reasonable legal and accounting fees, arising out of or resulting from your use of the Website and the Materials or your breach of these Terms and Conditions.




General navigation: Home | Member roster | Consultation | Our history | Contact
News & Events: Literature news archives | EM and related events
Education: CME monographs | Articles & Print
Publications: Member publications | Monographs

Legal information

EMCREG™ - International
4555 Lake Forest Drive
Suite 650
Cincinnati, Ohio 45242

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

15 May 2008
A recent NEJM article reports that cardiac troponin elevation is associated with increased in-hospital mortality in patients with acute decompensated heart failure
15 May 2008
Research suggestes that the use of multiple biomarkers of renal and cardiovascular abnormalities improves cardiovascular disease risk stratification.
13 May 2008
A study reports that STEMI patients with combined factors such as older age, female gender, Hispanic or Black race, and diabetes have much longer delays in STEMI presentation.
12 May 2008
Bleeding risk cut in half in ACS patients by switching from unfractionated heparin or low molecular weight heparin to bivalirudin.
9 May 2008
Researchers report that the additional patients diagnosed with MI rather than UA since the definition of MI was redefined have an even higher long-term mortality.
9 May 2008
Experts suggest that discrepancies in recommendations for optimal anticoagulation treatment in updated US and European ACS management guidelines are confusing for clinicians.
8 May 2008
Researchers report that "midregional" pro-atrial natriuretic peptide is a strong predictor of adverse outcome after AMI, and gives complementary information when combined with measurement of the prohormone of BNP.
7 May 2008
A study reports effective triage using a portable ultrasound device that can accurately screen emergency department patients with dyspnea for venous thromboembolism.
1 May 2008
Researchers in Israel propose that patients with transient ST-elevation myocardial infarction (TSTEMI) may benefit from immediate, intense medical therapy and an early invasive approach.
28 April 2008
Research suggests that monitoring levels of NT-proBNP is better than clinical assessment at predicting outcome in heart failure outpatients.
25 April 2008
Researchers test a new 15-minute rapid point-of-care D-dimer assay with diagnostic performance comparable to conventional laboratory D-dimer tests.
24 April 2008
The ACUITY data suggests ACS patients with diabetes are likely to have more ischemia and bleeding than other patients, but these adverse events can be minimized by bilvalirudin monotherapy
NEWS ARCHIVES:
©Copyright EMCREG-International™. All rights reserved